Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.
Cationic drugs and COVID-19 / O.V. Brenna, S.S. Torretta, L. Pignataro, F. Di Berardino. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 2058-7384. - 34(2020), pp. 1-3.
Titolo: | Cationic drugs and COVID-19 |
Autori: | BRENNA, ORESTE VITTORE (Primo) PIGNATARO, LORENZO (Penultimo) DI BERARDINO, FEDERICA (Ultimo) |
Parole Chiave: | COVID-19; cationic drugs; emergency; infection; pandemic |
Settore Scientifico Disciplinare: | Settore MED/31 - Otorinolaringoiatria |
Data di pubblicazione: | 2020 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1177/2058738420966078 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
2058738420966078(1).pdf | Publisher's version/PDF | Open Access Visualizza/Apri |